You are here Home Vaccines Vaccines Q-Vax Details for Q-Vax (Q fever) vaccine and its components. Listen Print Share Twitter Facebook Email Recently added This page was added on 04 June 2018. Updates made This page was updated on [date-counter-updated-date]. View history of updates Sponsor Seqirus Administration route Subcutaneous injection Vaccine group Q fever vaccines Description: Registered for use in adults. Each 0.5 mL monodose pre-filled syringe contains: 25 µg purified killed suspension of Coxiella burnetii 0.01% w/v thiomersal traces of formalin May contain egg proteins. For Product Information and Consumer Medicine Information about Q-Vax visit the Therapeutic Goods Administration website. Additional vaccine information For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s. Allergy advice May contain egg proteins. Related diseases Q fever Page history Last updated 4 June 2018 Last reviewed 4 June 2018 Is there anything wrong with this page? Help us improve the Australian Immunisation Handbook What you were doing? (required) What went wrong? (required) Leave this field blank
